LOGO.png
Nemaura Medical Reports Fiscal First Quarter 2023 Results and Provides Business Update
August 15, 2022 08:30 ET | Nemaura Medical, Inc
Loughborough, England, Aug. 15, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing a...
LOGO.png
Nemaura Medical Reports Financial Results and Provides Business Update for the Fiscal Year Ended March 31, 2022
June 30, 2022 08:00 ET | Nemaura Medical, Inc
Loughborough, England, June 30, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing a...
LOGO.png
Nemaura Medical Strengthens Balance Sheet with Further Non-Dilutive Funding
May 23, 2022 06:30 ET | Nemaura Medical, Inc
Loughborough, England, May 23, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD), a medical technology company focused on commercializing a daily disposable wearable glucose sensor and...
Happy Bob Integrates With Dexcom CGM to Provide a Playful Way to Engage With Real-Time Glucose Values and Improve Overall Self-Care
March 08, 2022 07:00 ET | Harald AI
HELSINKI, March 08, 2022 (GLOBE NEWSWIRE) -- Diabetes tech startup Harald AI today introduced a more expansive way for Dexcom Continuous Glucose Monitoring (CGM) System users to engage with their...
Vantage Market Research.png
Global Continuous Glucose Monitoring Devices (CGM) Market to Hit USD 13.24 Billion by 2028; Continuous Glucose Monitoring Devices Industry CAGR of 10.8% between 2022-2028; Exclusive Insight Report by Vantage Market Research
March 08, 2022 03:12 ET | Vantage Market Research
WASHINGTON, March 08, 2022 (GLOBE NEWSWIRE) -- Vantage Market Research’s recent analysis of the Global Continuous Glucose Monitoring Devices Market finds that rising incidence of diabetes is...
LOGO.png
Nemaura Medical Announces Fiscal Second Quarter 2022 Financial Results and Provides Business Update
November 15, 2021 09:30 ET | Nemaura Medical, Inc
Loughborough, England, Nov. 15, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing...
ExpressionMed Celebrates Diabetes Awareness Month With NFT Dragons, Donations & More
November 11, 2021 14:37 ET | ExpressionMed
MINNEAPOLIS, Nov. 11, 2021 (GLOBE NEWSWIRE) -- What do dragons, NFTs, and medical tape have in common? They all work together to improve the lives of people living with diabetes. ExpressionMed,...
Innovation Zed Announce Non-Invasive Continuous Glucose Monitoring Project and Appointment of a New Researcher
October 11, 2021 01:00 ET | Innovation Zed Ltd.
DUBLIN, Oct. 11, 2021 (GLOBE NEWSWIRE) -- Innovation Zed Ltd., developer of novel diabetes technologies (the InsulCheck range), announced further advancement in their research of technologies for...
LOGO.png
Nemaura Medical Announces Commercial Agreement with UK Licensee
September 27, 2021 08:00 ET | Nemaura Medical, Inc
Nemaura has previously placed order for 200,000 CGMs in anticipation of commercial ramp-up Loughborough, England, Sept. 27, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD)(“Nemaura”...
LOGO.png
Nemaura Medical to Present at the Benzinga Healthcare Small Cap Conference
September 21, 2021 08:30 ET | Nemaura Medical, Inc
Loughborough, England, Sept. 21, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on developing and commercializing non-invasive wearable...